Lingeng Lu
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 28
- MicroRNA in disease regulation 14
- Complementary and Manual Therapy top 0.5%
- Molecular Biology top 2%
- RNA modifications and cancer 22
- Epigenetics and DNA Methylation 16
- RNA Research and Splicing 14
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 12
- Pancreatic and Hepatic Oncology Research 12
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 11
- Co-authors
- Herbert YuDionyssios KatsarosHarvey A. RischYingqun HuangIrene A. Rigault de la LongraisLei YanAmanda N. KallenMark Kidd
- Journals
- Breast Cancer Research and Treatment (9 papers)Cancers (6 papers)Osteoarthritis and Cartilage (6 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Lingeng Lu
188 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Cancer Research 2.8k
- Complementary and Manual Therapy 247
- Molecular Biology 3.8k
- Oncology 1.2k
- Obstetrics and Gynecology 236
Countries citing papers authored by Lingeng Lu
This map shows the geographic impact of Lingeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingeng Lu more than expected).
Fields of papers citing papers by Lingeng Lu
This network shows the impact of papers produced by Lingeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingeng Lu. The network helps show where Lingeng Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 17 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 109 | |
| 12 | 2021 | 39 | |
| 13 | 2020 | 15 | |
| 14 | 2018 | 17 | |
| 15 | 2018 | 48 | |
| 16 | 2018 | 3 | |
| 17 | 2018 | 99 | |
| 18 | 2016 | 50 | |
| 19 | 2012 | 59 | |
| 20 | 2005 | 37 |
About Lingeng Lu
Lingeng Lu is a scholar working on Cancer Research, Complementary and Manual Therapy and Oncology, having authored 193 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (28 papers), RNA modifications and cancer (22 papers), Epigenetics and DNA Methylation (16 papers), MicroRNA in disease regulation (14 papers), RNA Research and Splicing (14 papers), Cancer Immunotherapy and Biomarkers (12 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Endometrial and Cervical Cancer Treatments (11 papers). The work is most often cited by research in Cancer Research (2.8k citations), Complementary and Manual Therapy (247 citations) and Molecular Biology (3.8k citations). Lingeng Lu has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Herbert Yu, Dionyssios Katsaros, Harvey A. Risch, Yingqun Huang, Irene A. Rigault de la Longrais, Lei Yan, Amanda N. Kallen, Mark Kidd, Jie Xu and Suresh D. Pillai. Their work appears in journals such as Breast Cancer Research and Treatment, Cancers, Osteoarthritis and Cartilage, Cancer Research and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.